186 related articles for article (PubMed ID: 20739387)
1. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia.
Schalin-Jäntti C; Mornet E; Lamminen A; Välimäki MJ
J Clin Endocrinol Metab; 2010 Dec; 95(12):5174-9. PubMed ID: 20739387
[TBL] [Abstract][Full Text] [Related]
2. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia.
Gagnon C; Sims NA; Mumm S; McAuley SA; Jung C; Poulton IJ; Ng KW; Ebeling PR
J Clin Endocrinol Metab; 2010 Mar; 95(3):1007-12. PubMed ID: 20089612
[TBL] [Abstract][Full Text] [Related]
3. ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.
Camacho PM; Mazhari AM; Wilczynski C; Kadanoff R; Mumm S; Whyte MP
Endocr Pract; 2016 Aug; 22(8):941-50. PubMed ID: 27042741
[TBL] [Abstract][Full Text] [Related]
4. Adult hypophosphatasia treated with teriparatide.
Whyte MP; Mumm S; Deal C
J Clin Endocrinol Metab; 2007 Apr; 92(4):1203-8. PubMed ID: 17213282
[TBL] [Abstract][Full Text] [Related]
5. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.
Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR
J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187
[TBL] [Abstract][Full Text] [Related]
6. Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model.
Koh AJ; Nam HK; Michalski MN; Do J; McCauley LK; Hatch NE
Osteoporos Int; 2022 Nov; 33(11):2423-2433. PubMed ID: 35871207
[TBL] [Abstract][Full Text] [Related]
7. Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I
Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263
[TBL] [Abstract][Full Text] [Related]
8. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia.
Sutton RA; Mumm S; Coburn SP; Ericson KL; Whyte MP
J Bone Miner Res; 2012 May; 27(5):987-94. PubMed ID: 22322541
[TBL] [Abstract][Full Text] [Related]
9. Adult hypophosphatasia treated with reduced frequency of teriparatide dosing.
Polyzos SA; Tournis S; Goulas A; Kollia P; Whyte MP
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):584-589. PubMed ID: 34854399
[TBL] [Abstract][Full Text] [Related]
10. Atypical femoral fracture in a 51-year-old woman: Revealing a hypophosphatasia.
Maman E; Briot K; Roux C
Joint Bone Spine; 2016 May; 83(3):346-8. PubMed ID: 26992955
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry.
Högler W; Langman C; Gomes da Silva H; Fang S; Linglart A; Ozono K; Petryk A; Rockman-Greenberg C; Seefried L; Kishnani PS
BMC Musculoskelet Disord; 2019 Feb; 20(1):80. PubMed ID: 30764793
[TBL] [Abstract][Full Text] [Related]
12. ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia.
Marini F; Masi L; Giusti F; Cianferotti L; Cioppi F; Marcucci G; Ciuffi S; Biver E; Toro G; Iolascon G; Iantomasi T; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2087-e2094. PubMed ID: 34935951
[TBL] [Abstract][Full Text] [Related]
13. Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment.
Cundy T; Michigami T; Tachikawa K; Dray M; Collins JF; Paschalis EP; Gamsjaeger S; Roschger A; Fratzl-Zelman N; Roschger P; Klaushofer K
J Bone Miner Res; 2015 Sep; 30(9):1726-37. PubMed ID: 25736332
[TBL] [Abstract][Full Text] [Related]
14. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters.
Guañabens N; Mumm S; Möller I; González-Roca E; Peris P; Demertzis JL; Whyte MP
J Bone Miner Res; 2014 Apr; 29(4):929-34. PubMed ID: 24123110
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
16. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
[TBL] [Abstract][Full Text] [Related]
17. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.
Lin EL; Gottesman GS; McAlister WH; Bijanki VN; Mack KE; Griffin DM; Mumm S; Whyte MP
Bone; 2020 Jul; 136():115322. PubMed ID: 32200022
[TBL] [Abstract][Full Text] [Related]
18. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
[TBL] [Abstract][Full Text] [Related]
19. Adult hypophosphatasia with compound heterozygous p.Phe327Leu missense and c.1559delT frameshift mutations in tissue-nonspecific alkaline phosphatase gene: a case report.
Fukushima K; Kawai-Kowase K; Yonemoto Y; Fujiwara M; Sato H; Sato M; Kubota T; Ozono K; Tamura J
J Med Case Rep; 2019 Apr; 13(1):101. PubMed ID: 31014398
[TBL] [Abstract][Full Text] [Related]
20. A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.
Ng E; Ashkar C; Seeman E; Schneider HG; Nguyen H; Ebeling PR; Sztal-Mazer S
Osteoporos Int; 2023 Feb; 34(2):327-337. PubMed ID: 36434431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]